The fight against cancer in the present day has intensified. Despite the fact that no cure has been discovered yet, scientists and researchers do not relent. They are still waging war against it in all possible ways. Mr Eric Lefkofsky has joined in the fight and is providing data that will assist in the better treatment of breast cancer.
Eric Lefkofsky is the founder of Tempus. It is a startup cancer-fighting enterprise from Groupon. It aims at providing doctors at the University of Chicago crucial data that will aid in the better administration of treatment to breast cancer patients. The organization has joined forces with the University of Chicago to provide molecular sequencing and analysis for their breast cancer specialists. It has, therefore, created personalized treatment plans for patients from this analysis. It has purposed to analyze data from as many breast cancer patients to help practitioners expose patterns that forecast how patients will respond to treatment. Click here to know more.
Breast cancer is the most common form of cancer. Unfortunately, petite data on the patients is available. It has made the formulation of therapy a hectic task for physicians due to lack of reference points. Therefore, provision of this data is the aim of Tempus as it will help lead to better treatment and to ultimately improved patient outcomes. Hence, it utilizes the services of machines learning and genomic sequencing to assist doctors in making immediate personalized treatment decisions.
Erick Lefkofsky has heavily invested in the healthcare sector. He is a founding partner of Lightbank as well as co-founder and Chairman of Groupon. Moreover, he has served in other organizations like Mediaocean, Echo Global Logistics, and InnerWorking. Also, he has established the Lefkofsky Family Foundation, a private charitable organization. He is a graduate of Michigan University. Eric’s aim is to live in a breast cancer-free society.